Trump Administration’s Cuts Threaten Cancer Research and Public Health
The Trump administration’s new policy capping indirect costs for NIH research grants at 15% violates a congressional provision, annually included since 2018, explicitly prohibiting such changes. This action jeopardizes billions in funding for crucial research on diseases like cancer and Alzheimer’s. The policy illegally cuts funding for shared research costs, including lab equipment and staff, essential for maintaining the U.S.’s global research leadership. This unlawful action is expected to be challenged in court.
John Q. Hosedrinker